These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25842363)

  • 21. Synthesis of a potent photoreactive acidic γ-secretase modulator for target identification in cells.
    Rennhack A; Jumpertz T; Ness J; Baches S; Pietrzik CU; Weggen S; Bulic B
    Bioorg Med Chem; 2012 Nov; 20(21):6523-32. PubMed ID: 23000293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates.
    Mitani Y; Akashiba H; Saita K; Yarimizu J; Uchino H; Okabe M; Asai M; Yamasaki S; Nozawa T; Ishikawa N; Shitaka Y; Ni K; Matsuoka N
    Neuropharmacology; 2014 Apr; 79():412-9. PubMed ID: 24373902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic ceramide analogues increase amyloid-β 42 production by modulating γ-secretase activity.
    Takasugi N; Sasaki T; Shinohara M; Iwatsubo T; Tomita T
    Biochem Biophys Res Commun; 2015 Feb; 457(2):194-9. PubMed ID: 25545059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of aryl aminothiazole γ-secretase modulators with novel effects on amyloid β-peptide production.
    Bhattarai S; Liu L; Wolfe MS
    Bioorg Med Chem Lett; 2021 Dec; 54():128446. PubMed ID: 34767913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revisiting the peripheral sink hypothesis: inhibiting BACE1 activity in the periphery does not alter β-amyloid levels in the CNS.
    Georgievska B; Gustavsson S; Lundkvist J; Neelissen J; Eketjäll S; Ramberg V; Bueters T; Agerman K; Juréus A; Svensson S; Berg S; Fälting J; Lendahl U
    J Neurochem; 2015 Feb; 132(4):477-86. PubMed ID: 25156639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishing the relationship between in vitro potency, pharmacokinetic, and pharmacodynamic parameters in a series of orally available, hydroxyethylamine-derived β-secretase inhibitors.
    Wood S; Wen PH; Zhang J; Zhu L; Luo Y; Babu-Khan S; Chen K; Pham R; Esmay J; Dineen TA; Kaller MR; Weiss MM; Hitchcock SA; Citron M; Zhong W; Hickman D; Williamson T
    J Pharmacol Exp Ther; 2012 Nov; 343(2):460-7. PubMed ID: 22911925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Piperazinyl pyrimidine derivatives as potent gamma-secretase modulators.
    Rivkin A; Ahearn SP; Chichetti SM; Kim YR; Li C; Rosenau A; Kattar SD; Jung J; Shah S; Hughes BL; Crispino JL; Middleton RE; Szewczak AA; Munoz B; Shearman MS
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1269-71. PubMed ID: 20022243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivatives as γ-secretase modulators (Part 2).
    Takai T; Koike T; Nakamura M; Kajita Y; Yamashita T; Taya N; Tsukamoto T; Watanabe T; Murakami K; Igari T; Kamata M
    Bioorg Med Chem; 2016 Jul; 24(14):3192-206. PubMed ID: 27255179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator.
    Jung JI; Price AR; Ladd TB; Ran Y; Park HJ; Ceballos-Diaz C; Smithson LA; Hochhaus G; Tang Y; Akula R; Ba S; Koo EH; Shapiro G; Felsenstein KM; Golde TE
    Mol Neurodegener; 2015 Jul; 10():29. PubMed ID: 26169917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Piperidine-derived gamma-secretase modulators.
    Hall A; Elliott RL; Giblin GM; Hussain I; Musgrave J; Naylor A; Sasse R; Smith B
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1306-11. PubMed ID: 20056541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent γ-secretase inhibitors/modulators interact with amyloid-β fibrils but do not inhibit fibrillation: a high-resolution NMR study.
    Yesuvadian R; Krishnamoorthy J; Ramamoorthy A; Bhunia A
    Biochem Biophys Res Commun; 2014 May; 447(4):590-5. PubMed ID: 24747079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imatinib methanesulfonate reduces hippocampal amyloid-β and restores cognitive function following repeated endotoxin exposure.
    Weintraub MK; Bisson CM; Nouri JN; Vinson BT; Eimerbrink MJ; Kranjac D; Boehm GW; Chumley MJ
    Brain Behav Immun; 2013 Oct; 33():24-8. PubMed ID: 23665252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of novel triazolobenzazepinones as γ-secretase modulators with central Aβ42 lowering in rodents and rhesus monkeys.
    Fischer C; Zultanski SL; Zhou H; Methot JL; Shah S; Hayashi I; Hughes BL; Moxham CM; Bays NW; Smotrov N; Hill AD; Pan BS; Wu Z; Moy LY; Tanga F; Kenific C; Cruz JC; Walker D; Bouthillette M; Nikov GN; Deshmukh SV; Jeliazkova-Mecheva VV; Diaz D; Michener MS; Cook JJ; Munoz B; Shearman MS
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3488-94. PubMed ID: 26212776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of novel methoxypyridine-derived gamma-secretase modulators.
    Rynearson KD; Buckle RN; Herr RJ; Mayhew NJ; Chen X; Paquette WD; Sakwa SA; Yang J; Barnes KD; Nguyen P; Mobley WC; Johnson G; Lin JH; Tanzi RE; Wagner SL
    Bioorg Med Chem; 2020 Nov; 28(22):115734. PubMed ID: 33007551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of 4-aminomethylphenylacetic acids as γ-secretase modulators via a scaffold design approach.
    Xin Z; Peng H; Zhang A; Talreja T; Kumaravel G; Xu L; Rohde E; Jung MY; Shackett MN; Kocisko D; Chollate S; Dunah AW; Snodgrass-Belt PA; Arnold HM; Taveras AG; Rhodes KJ; Scannevin RH
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7277-80. PubMed ID: 22061640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo characterization of Abeta(40) changes in brain and cerebrospinal fluid using the novel gamma-secretase inhibitor N-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) in the rat.
    Best JD; Jay MT; Otu F; Churcher I; Reilly M; Morentin-Gutierrez P; Pattison C; Harrison T; Shearman MS; Atack JR
    J Pharmacol Exp Ther; 2006 May; 317(2):786-90. PubMed ID: 16443723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. γ-Secretase modulator in Alzheimer's disease: shifting the end.
    Xia W; Wong ST; Hanlon E; Morin P
    J Alzheimers Dis; 2012; 31(4):685-96. PubMed ID: 22710916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of tetrahydroindazoles as a novel class of potent and in vivo efficacious gamma secretase modulators.
    Gerlach K; Hobson S; Eickmeier C; Groß U; Braun C; Sieger P; Garneau M; Hoerer S; Heine N
    Bioorg Med Chem; 2018 Jul; 26(12):3227-3241. PubMed ID: 29735425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and optimization of tricyclic gamma-secretase modulators.
    Shi J; Zuev D; Xu L; Lentz KA; Grace JE; Toyn JH; Olson RE; Macor JE; Thompson LA
    Bioorg Med Chem Lett; 2016 Mar; 26(5):1498-502. PubMed ID: 26848108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.